This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765–81.FerlayJParkinDMSteliarova-FoucherEEstimates of cancer incidence and mortality in Europe in 2008Eur J Cancer2010467658110.1016/j.ejca.2009.12.014Search in Google Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161699010.3322/caac.20107Search in Google Scholar
Krejs GJ. Pancreatic cancer: epidemiology and risk factors. Dig Dis 2010; 28: 355–8.KrejsGJPancreatic cancer: epidemiology and risk factorsDig Dis201028355810.1159/000319414Search in Google Scholar
Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009; 27: 5513–8.CunninghamDChauIStockenDDValleJWSmithDStewardWPhase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancerJ Clin Oncol2009275513810.1200/JCO.2009.24.2446Search in Google Scholar
Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403–13.BurrisHAMooreMJAndersenJGreenMRRothenbergMLModianoMRImprovements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialJ Clin Oncol19971524031310.1200/JCO.1997.15.6.2403Search in Google Scholar
Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817–25.ConroyTDesseigneFYchouMBoucheOGuimbaudRBecouarnYFOLFIRINOX versus gemcitabine for metastatic pancreatic cancerN Engl J Med201136418172510.1056/NEJMoa1011923Search in Google Scholar
Neumann E, Kakorin S, Toensing K. Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 1999; 48: 3–16.NeumannEKakorinSToensingKFundamentals of electroporative delivery of drugs and genesBioelectrochem Bioenerg19994831610.1016/S0302-4598(99)00008-2Search in Google Scholar
Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1993; 1154: 51–63.OrlowskiSMirLMCell electropermeabilization: a new tool for biochemical and pharmacological studiesBiochim Biophys Acta19931154516310.1016/0304-4157(93)90016-HSearch in Google Scholar
Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437–47.GehlJElectroporation: theory and methods perspectives for drug delivery gene therapy and researchActa Physiol Scand20031774374710.1046/j.1365-201X.2003.01093.xSearch in Google Scholar
Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68–72.MirLMOrlowskiSBelehradekJJrPaolettiCElectrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEur J Cancer199127687210.1016/0277-5379(91)90064-KSearch in Google Scholar
Sersa G, Novakovic S, Miklavcic D. Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett 1993; 69: 81–4.SersaGNovakovicSMiklavcicDPotentiation of bleomycin antitumor effectiveness by electrotherapyCancer Lett19936981410.1016/0304-3835(93)90159-7Search in Google Scholar
Nanda GS, Sun FX, Hofmann GA, Hoffman RM, Dev SB. Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model. Anticancer Res 1998; 18(3A): 1361–6.NandaGSSunFXHofmannGAHoffmanRMDevSBElectroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal modelAnticancer Res199818(3A)13616Search in Google Scholar
Jaroszeski MJ, Illingworth P, Pottinger C, Hyacinthe M, Heller R. Electrically mediated drug delivery for treating subcutaneous and orthotopic pancreatic adenocarcinoma in a hamster model. Anticancer Res 1999; 19(2A): 989–94.JaroszeskiMJIllingworthPPottingerCHyacintheMHellerRElectrically mediated drug delivery for treating subcutaneous and orthotopic pancreatic adenocarcinoma in a hamster modelAnticancer Res199919(2A)98994Search in Google Scholar
Liu X, Tian X, Wang F, Ma Y, Kornmann M, Yang Y. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling. Eur J Cancer 2014; 50: 2251–62.LiuXTianXWangFMaYKornmannMYangYBRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signallingEur J Cancer20145022516210.1016/j.ejca.2014.05.017Search in Google Scholar
Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, et al. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Int J Surg 2015; 18: 230–6.GranataVFuscoRPiccirilloMPalaiaRPetrilloALastoriaSElectrochemotherapy in locally advanced pancreatic cancer: Preliminary resultsInt J Surg201518230610.1016/j.ijsu.2015.04.055Search in Google Scholar
Miklavcic D, Sersa G, Brecelj E, Gehl J, Soden D, Bianchi G, et al. Electrochemotherapy: technological advancements for efficient electropo-ration-based treatment of internal tumors. Med Biol Eng Comput 2012; 50: 1213–25.MiklavcicDSersaGBreceljEGehlJSodenDBianchiGElectrochemotherapy: technological advancements for efficient electropo-ration-based treatment of internal tumorsMed Biol Eng Comput20125012132510.1007/s11517-012-0991-8Search in Google Scholar
Girelli R, Prejano S, Cataldo I, Corbo V, Martini L, Scarpa A, et al. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol 2015; 49: 147–54.GirelliRPrejanoSCataldoICorboVMartiniLScarpaAFeasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigationRadiol Oncol2015491475410.1515/raon-2015-0013Search in Google Scholar
Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000; 11: 201–8.JaroszeskiMJDangVPottingerCHickeyJGilbertRHellerRToxicity of anticancer agents mediated by electroporation in vitroAnticancer Drugs200011201810.1097/00001813-200003000-00008Search in Google Scholar
Cadossi R, Ronchetti M, Cadossi M. Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy. Future Oncol 2014; 10: 877–90.CadossiRRonchettiMCadossiMLocally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapyFuture Oncol2014108779010.2217/fon.13.235Search in Google Scholar
Miklavcic D, Mali B, Kos B, Heller R, Sersa G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 2014; 13: 29.MiklavcicDMaliBKosBHellerRSersaGElectrochemotherapy: from the drawing board into medical practiceBiomed Eng Online2014132910.1186/1475-925X-13-29Search in Google Scholar
Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998; 9: 319–25.GehlJSkovsgaardTMirLMEnhancement of cytotoxicity by electropermeabilization: an improved method for screening drugsAnticancer Drugs199893192510.1097/00001813-199804000-00005Search in Google Scholar
Poddevin B, Orlowski S, Belehradek J Jr, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991; 42(Suppl): S67-75.PoddevinBOrlowskiSBelehradekJJrMirLMVery high cytotoxicity of bleomycin introduced into the cytosol of cells in cultureBiochem Pharmacol199142(Suppl)S677510.1016/0006-2952(91)90394-KSearch in Google Scholar
Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemo-therapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995; 55: 3450–5.SersaGCemazarMMiklavcicDAntitumor effectiveness of electrochemo-therapy with cis-diamminedichloroplatinum(II) in miceCancer Res19955534505Search in Google Scholar
Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O’Reily S, et al. Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg 2007; 245: 469–79.LarkinJOCollinsCGAaronsSTangneyMWhelanMO’ReilySElectrochemotherapy: aspects of preclinical development and early clinical experienceAnn Surg20072454697910.1097/01.sla.0000250419.36053.33187702717435555Search in Google Scholar
Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnology 2007; 5: 3.BishtSFeldmannGSoniSRaviRKarikarCMaitraAPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075310.1186/1477-3155-5-3186803717439648Search in Google Scholar
Kishore B, Khare P, Gupta RJ, Bisht S, Majumdar K. Hemoglobin E disease in North Indian population: a report of 11 cases. Hematology 2007; 12: 343–7.KishoreBKharePGuptaRJBishtSMajumdarKHemoglobin E disease in North Indian population: a report of 11 casesHematology200712343710.1080/1024533070125524717654063Search in Google Scholar
Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Barbieri M, Albino V, et al. Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth. Infect Agent Cancer 2015; 10: 22.BimonteSLeongitoMBarbieriADel VecchioVBarbieriMAlbinoVInhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growthInfect Agent Cancer2015102210.1186/s13027-015-0016-y451860126225138Search in Google Scholar
Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 2011; 104: 22–8.BowerMSherwoodLLiYMartinRIrreversible electroporation of the pancreas: definitive local therapy without systemic effectsJ Surg Oncol201110422810.1016/j.jss.2009.11.620Search in Google Scholar
Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 2010; 12: 348–51.CharpentierKPWolfFNobleLWinnBResnickMDupuyDEIrreversible electroporation of the pancreas in swine: a pilot studyHPB (Oxford)2010123485110.1111/j.1477-2574.2010.00174.x295182420590911Search in Google Scholar
Martin RC. Use of irreversible electroporation in unresectable pancreatic cancer. Hepatobiliary Surg Nutr 2015; 4: 211–5.MartinRCUse of irreversible electroporation in unresectable pancreatic cancerHepatobiliary Surg Nutr201542115Search in Google Scholar
Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 2011; 13: 168–73.CharpentierKPWolfFNobleLWinnBResnickMDupuyDEIrreversible electroporation of the liver and liver hilum in swineHPB (Oxford)2011131687310.1111/j.1477-2574.2010.00261.x304896721309933Search in Google Scholar
Jose A, Sobrevals L, Ivorra A, Fillat C. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Lett 2012; 317: 16–23.JoseASobrevalsLIvorraAFillatCIrreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse modelsCancer Lett2012317162310.1016/j.canlet.2011.11.00422079741Search in Google Scholar
Philips P, Li Y, Li S, St Hill CR, Martin RC. Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model. Mol Ther Methods Clin Dev 2015; 2: 15001.PhilipsPLiYLiSHillCRStMartinRCEfficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine modelMol Ther Methods Clin Dev201521500110.1038/mtm.2015.1444499526029712Search in Google Scholar
Philips P, Li Y, Martin RC 2nd. Low-energy DC current ablation in a mouse tumor model. Meth Mol Biol 2014; 1121: 257–65.PhilipsPLiYMartinRC2ndLow-energy DC current ablation in a mouse tumor modelMeth Mol Biol201411212576510.1007/978-1-4614-9632-8_2324510830Search in Google Scholar
Sersa G, Cemazar M, Snoj M. Electrochemotherapy of tumours. Curr Oncol 2009; 16: 34–5.SersaGCemazarMSnojMElectrochemotherapy of tumoursCurr Oncol20091634510.3747/co.v16i2.368Search in Google Scholar
Roux S, Bernat C, Al-Sakere B, Ghiringhelli F, Opolon P, Carpentier AF, et al. Tumor destruction using electrochemotherapy followed by CpG oligode-oxynucleotide injection induces distant tumor responses. Cancer Immunol Immunother 2008; 57: 1291–300.RouxSBernatCAl-SakereBGhiringhelliFOpolonPCarpentierAFTumor destruction using electrochemotherapy followed by CpG oligode-oxynucleotide injection induces distant tumor responsesCancer Immunol Immunother200857129130010.1007/s00262-008-0462-018259749Search in Google Scholar
Dev SB, Hofmann GA, Nanda GS. Treatment of human pancreatic tumors xenografted in nude mice by chemotherapy combined with pulsed electric fields. Methods Mol Med 2000; 37: 277–83.DevSBHofmannGANandaGSTreatment of human pancreatic tumors xenografted in nude mice by chemotherapy combined with pulsed electric fieldsMethods Mol Med2000372778310.1385/1-59259-080-2:277Search in Google Scholar
Tafuto S, von Arx C, De Divitiis C, Tracey Maura C, Palaia R, Albino V, et al. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Int J Surg 2015; 21(Suppl 1): S78-82.TafutoSvon ArxCDe DivitiisCTracey MauraCPalaiaRAlbinoVElectrochemotherapy as a new approach on pancreatic cancer and on liver metastasesInt J Surg201521(Suppl 1)S788210.1016/j.ijsu.2015.04.09526123385Search in Google Scholar
Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011; 10: 475–85.EdhemovicIGadzijevEMBreceljEMiklavcicDKosBZupanicAElectrochemotherapy: a new technological approach in treatment of metastases in the liverTechnol Cancer Res Treat2011104758510.7785/tcrt.2012.500224452741421895032Search in Google Scholar
Girelli R, Frigerio I, Salvia R, Barbi E, Tinazzi Martini P, Bassi C. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg. 2010; 97: 220–5.GirelliRFrigerioISalviaRBarbiETinazzi MartiniPBassiCFeasibility and safety of radiofrequency ablation for locally advanced pancreatic cancerBr J Surg.201097220510.1002/bjs.680020069610Search in Google Scholar
Girelli R, Frigerio I, Giardino A, Regi P, Gobbo S, Malleo G, et al. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbecks Arch Surg 2013; 398: 63–9.GirelliRFrigerioIGiardinoARegiPGobboSMalleoGResults of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinomaLangenbecks Arch Surg201339863910.1007/s00423-012-1011-z23053459Search in Google Scholar
Giardino A, Girelli R, Frigerio I, Regi P, Cantore M, Alessandra A, et al. Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB (Oxford) 2013; 15: 623–7.GiardinoAGirelliRFrigerioIRegiPCantoreMAlessandraATriple approach strategy for patients with locally advanced pancreatic carcinomaHPB (Oxford)201315623710.1111/hpb.12027373158423458679Search in Google Scholar
Cantore M, Girelli R, Mambrini A, Frigerio I, Boz G, Salvia R, et al. Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. Br J Surg 2012; 99: 1083–8.CantoreMGirelliRMambriniAFrigerioIBozGSalviaRCombined modality treatment for patients with locally advanced pancreatic adenocarcinomaBr J Surg2012991083810.1002/bjs.878922648697Search in Google Scholar
Matsui Y, Nakagawa A, Kamiyama Y, Yamamoto K, Kubo N, Nakase Y. Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 2000; 20: 14–20.MatsuiYNakagawaAKamiyamaYYamamotoKKuboNNakaseYSelective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heatingPancreas200020142010.1097/00006676-200001000-0000210630378Search in Google Scholar
Young SJ. Irreversible electroporation and the pancreas: What we know and where we are going? World J Gastrointest Surg 2015; 7: 138–44.YoungSJIrreversible electroporation and the pancreas: What we know and where we are going?World J Gastrointest Surg201571384410.4240/wjgs.v7.i8.138455084026328033Search in Google Scholar
Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc interv Radiol 2014; 25: 997–1011.SchefferHJNielsenKde JongMCvan TilborgAAVieveenJMBouwmanARIrreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacyJ Vasc interv Radiol201425997101110.1016/j.jvir.2014.01.02824656178Search in Google Scholar
Trueba-Arguinarena FJ, de Prado-Otero DS, Poves-Alvarez R. Pancreatic adenocarcinoma treated with irreversible electroporation Case Report: first experience and outcome. Medicine (Baltimore) 2015; 94: e946.Trueba-ArguinarenaFJde Prado-OteroDSPoves-AlvarezRPancreatic adenocarcinoma treated with irreversible electroporation Case Report: first experience and outcomeMedicine (Baltimore)201594e94610.1097/MD.0000000000000946450463226131840Search in Google Scholar
Gall TM, Thompson Z, Dinneen EP, Sodergren M, Pai M, Frampton AE, et al. Surgical techniques for improving outcomes in pancreatic ductal adenocarcinoma. Expert Rew Gastroenter Hepatol 2014; 8: 241–6.GallTMThompsonZDinneenEPSodergrenMPaiMFramptonAESurgical techniques for improving outcomes in pancreatic ductal adenocarcinomaExpert Rew Gastroenter Hepatol20148241610.1586/17474124.2014.88125124491183Search in Google Scholar
Weiss MJ, Wolfgang CL. Irreversible electroporation: a novel pancreatic cancer therapy. Curr Probl Cancer 2013; 37: 262–5.WeissMJWolfgangCLIrreversible electroporation: a novel pancreatic cancer therapyCurr Probl Cancer201337262510.1016/j.currproblcancer.2013.10.00224331180Search in Google Scholar
Martin RG, II, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 2013; 20: 443–9.MartinRGIIMcFarlandKEllisSVelanovichVIrreversible electroporation in locally advanced pancreatic cancer: potential improved overall survivalAnn Surg Oncol201320443910.1245/s10434-012-2736-123128941Search in Google Scholar
Long G, Bakos G, Shires PK, Gritter L, Crissman JW, Harris JL, et al. Histological and finite element analysis of cell death due to irreversible electroporation. Technol Cancer Res Treat 2014; 13: 561–9.LongGBakosGShiresPKGritterLCrissmanJWHarrisJLHistological and finite element analysis of cell death due to irreversible electroporationTechnol Cancer Res Treat201413561910.7785/tcrtexpress.2013.600253452742724000980Search in Google Scholar
Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 2010; 110: 1305–9.BallCThomsonKRKavnoudiasHIrreversible electroporation: a new challenge in “out of operating theater” anesthesiaAnesth Analg20101101305910.1213/ANE.0b013e3181d27b3020142349Search in Google Scholar
Mali B, Gorjup V, Edhemovic I, Brecelj E, Cemazar M, Sersa G, et al. Electrochemotherapy of colorectal liver metastases - an observational study of its effects on the electrocardiogram. Biomed Eng Online 2015; 14(Suppl 3): S5.MaliBGorjupVEdhemovicIBreceljECemazarMSersaGElectrochemotherapy of colorectal liver metastases - an observational study of its effects on the electrocardiogramBiomed Eng Online201514(Suppl 3)S510.1186/1475-925X-14-S3-S5456511026356120Search in Google Scholar
Bagla S, Papadouris D. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. Journal of vascular and interventional radiology: J Vasc Interv Radiol 2012; 23: 142–5.BaglaSPapadourisDPercutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case reportJournal of vascular and interventional radiology: J Vasc Interv Radiol201223142510.1016/j.jvir.2011.10.00222221480Search in Google Scholar
Mansson C, Bergenfeldt M, Brahmstaedt R, Karlson BM, Nygren P, Nilsson A. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer. Anticancer Res 2014; 34: 289–93.ManssonCBergenfeldtMBrahmstaedtRKarlsonBMNygrenPNilssonASafety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancerAnticancer Res20143428993Search in Google Scholar
Paiella S, Butturini G, Frigerio I, Salvia R, Armatura G, Bacchion M, et al. Safety and feasibility of irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study. Digest Surg 2015; 32: 90–7.PaiellaSButturiniGFrigerioISalviaRArmaturaGBacchionMSafety and feasibility of irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective studyDigest Surg20153290710.1159/00037532325765775Search in Google Scholar
Martin RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 2013; 20(Suppl 3): S443-9.MartinRCMcFarlandKEllisSVelanovichVIrreversible electroporation in locally advanced pancreatic cancer: potential improved overall survivalAnn Surg Oncol201320(Suppl 3)S443910.1245/s10434-012-2736-123128941Search in Google Scholar
Martin RC, Philips P, Ellis S, Hayes D, Bagla S. Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation. BMC Cancer 2014; 14: 540.MartinRCPhilipsPEllisSHayesDBaglaSIrreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliationBMC Cancer20141454010.1186/1471-2407-14-540412413625064086Search in Google Scholar
